Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
---|
01/20/2011 | US20110015176 Substituted heteroarylamide oxazepinopyrimidone derivatives |
01/20/2011 | US20110015155 Deuterated 2, 4-Pyrimidinediamine Compounds and Prodrugs Thereof and Their Uses |
01/20/2011 | CA2778517A1 Substituted triazole and imidazole derivatives as gamma secretase modulators |
01/20/2011 | CA2768368A1 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
01/20/2011 | CA2768210A1 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt |
01/20/2011 | CA2768169A1 Aminopyridine derivatives for the treatment of tumors and inflammatory diseases |
01/19/2011 | EP2274983A1 Harmful arthropod control composition, and fused heterocyclic compound |
01/19/2011 | EP2274286A1 Keratin dyeing compounds, keratin dyeing compositions containing said compounds, and use thereof |
01/19/2011 | CN101948475A Isoflavone derivate-chromene (chroman) oxazines compound, preparation method and application thereof |
01/19/2011 | CN101948444A synthesized small molecular compound capable for transferring bioactive substances and applications thereof |
01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
01/19/2011 | CN101153043B Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
01/18/2011 | US7872128 6-chloro-N-(pyrimidin-5-yl)-3-(3-(trifluoromethyl)phenylamino)benzo[d]isoxazole-7-carboxamide; autoimmune disease, allergies, mastcytosis, mast cell related tumors and various fibrotic diseases |
01/18/2011 | US7872123 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates |
01/18/2011 | US7872122 reacting sirolimus with 2-ethoxyethyl pentafluorobenzene sulfonate under catalyzing condition using ethyl diiospropylamine or 2, 6-dimethyl pyridine as basic catalyst in the presence of an organic solvent (dichloromethane) to undergo a nucleophilic substitution reaction to obtain Biolimus A9 |
01/18/2011 | CA2477769C Ophthalmic composition comprising ascomycin |
01/13/2011 | WO2011005738A1 Bace inhibitors |
01/13/2011 | WO2011005295A1 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto |
01/13/2011 | WO2011003604A1 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof |
01/13/2011 | WO2010056633A8 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
01/13/2011 | US20110009639 Synthesis of enone intermediate |
01/13/2011 | US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
01/13/2011 | US20110009619 Polycyclic compound |
01/13/2011 | US20110009618 Methods of manufacturing crystalling forms of rapamycin analogs |
01/13/2011 | US20110009617 Ruthenium Catalysts and Uses Thereof |
01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
01/13/2011 | US20110009392 Gamma secretase modulators |
01/13/2011 | US20110009389 Imidazole derivative, their production and use |
01/13/2011 | US20110009382 Substituted Benzimidazoles, Benzothiazoles and Benzoxazoles |
01/13/2011 | US20110008288 Hepatitis c virus inhibitors |
01/13/2011 | CA2767476A1 Indazolyl-substituted dihydroisoxazolopyridines and methods of use thereof |
01/13/2011 | CA2764429A1 Condensed aminodihydrothiazine derivatives as bace inhibitors |
01/12/2011 | EP2272935A1 Ultraviolet absorbent compositions |
01/12/2011 | EP2272850A2 Process for purifying staurosporine |
01/12/2011 | EP2271650A1 Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands |
01/12/2011 | EP2271625A2 Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy |
01/12/2011 | EP2271345A1 Hcv ns3 protease inhibitors |
01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
01/12/2011 | CN101945867A Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
01/12/2011 | CN101945853A Selective androgen receptor modulators (sarms) and uses thereof |
01/12/2011 | CN101944571A Single-layer organic el device |
01/12/2011 | CN101941979A New production process of rifamycin sodium |
01/12/2011 | CN101445510B Pyridine macrocyclic crown ether-based stilbene compound |
01/11/2011 | US7868204 Inhibitors of histone deacetylase |
01/11/2011 | CA2518740C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
01/11/2011 | CA2430124C Lactam compounds and pharmaceutical use thereof |
01/06/2011 | WO2011002067A1 Heterocyclic compound and use thereof |
01/06/2011 | WO2011000481A1 Synthesis of pyrazine derivates |
01/06/2011 | US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
01/06/2011 | US20110003986 Synthesis of 2,4-Pyrimidinediamines |
01/06/2011 | US20110003969 Conjugation methods |
01/06/2011 | US20110003840 Pyridoindolobenzox-and thiazepine derivatives and uses thereof |
01/06/2011 | US20110003806 Heteroaryls and uses thereof |
01/06/2011 | US20110003803 Compositions and methods for treating ophthalmic, otic, or nasal infections |
01/06/2011 | US20110003802 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase |
01/06/2011 | US20110003801 Benzimidazole derivatives useful as trpm8 channel modulators |
01/06/2011 | US20110003800 Benzimidazole derivatives useful as trpm8 channel modulators |
01/06/2011 | US20110003798 Compounds and compositions as kinase inhibitors |
01/06/2011 | US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors |
01/06/2011 | US20110003789 5-aminocyclylmethyl-oxazolidin-2-one derivatives |
01/06/2011 | US20110003385 Regulated transcription of targeted genes and other biological events |
01/06/2011 | US20110002884 Therapeutic compounds |
01/05/2011 | EP2270113A1 Ultraviolet absorbent compositions |
01/05/2011 | EP2269651A2 Stabilisation of macrolides |
01/05/2011 | EP2269604A1 Treatment of solid tumours with rapamycin derivatives |
01/05/2011 | EP2269603A1 Treatment of solid tumours with rapamycin derivatives |
01/05/2011 | EP2268646A2 Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene a4 hydrolase |
01/05/2011 | EP2268645A1 Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof as allosteric modulators of mglur |
01/05/2011 | EP2268636A1 Gamma secretase modulators |
01/05/2011 | EP2268146A1 Indoline anti-cancer agents |
01/05/2011 | EP1661890B1 Ppar-activating compound and pharmaceutical composition containing same |
01/05/2011 | CN101939315A Gamma secretase modulators |
01/05/2011 | CN101939312A Gamma secretase modulators |
01/05/2011 | CN101939302A Mesoionic pesticides |
01/05/2011 | CN101089000B Spiro piperazine quaternary ammonium salt compound and its preparation method and application |
01/04/2011 | US7863306 Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
01/04/2011 | US7863288 protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents |
01/04/2011 | US7863281 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct |
01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
12/30/2010 | US20100331348 Tropane derivatives useful as pesticides |
12/30/2010 | US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
12/30/2010 | US20100331310 Bicycloamine derivatives |
12/30/2010 | US20100331305 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use |
12/30/2010 | US20100330021 Substituted (thiazol-2-yl)-amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
12/29/2010 | WO2010150840A1 N-substituted-cyclic amino derivative |
12/29/2010 | EP2266989A2 Heterocyclic derivatives |
12/29/2010 | EP2266968A2 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors |
12/29/2010 | EP2265620A1 Spiro derivatives of parthenin as novel anticancer agents |
12/29/2010 | EP2265601A1 Pyridazine derivatives as factor xia inhibitors |
12/29/2010 | EP2265275A2 Antiviral therapeutic agents |
12/29/2010 | EP2265270A1 2-aminopyridine kinase inhibitors |
12/29/2010 | EP1292573B1 Substituted thioacetamides |
12/29/2010 | CN1926132B Pyrazole compounds useful as protein kinase inhibitors |
12/29/2010 | CN1902196B Thiazole derivative |
12/29/2010 | CN101932578A Gamma secretase modulators |
12/29/2010 | CN101928291A Method for separating and purifying ansamitocin from precious orange synnema actinomycetes fermentation liquor |
12/29/2010 | CN101928290A Method for purifying pazufloxacin mesylate |
12/29/2010 | CN101103029B 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
12/28/2010 | US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide |
12/28/2010 | US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme |